Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
VTVT vTv Therapeutics
- 21.7050
- +0.5050+2.38%
Close Feb 14 16:00 ET
- 21.7050
- 0.00000.00%
Post 20:01 ET
56.70MMarket Cap-4.97P/E (TTM)
22.3000High19.5500Low11.52KVolume20.3300Open21.2000Pre Close245.83KTurnover1.08%Turnover RatioLossP/E (Static)2.61MShares30.990052wk High3.78P/B23.07MFloat Cap8.100052wk Low--Dividend TTM1.06MShs Float560.0000Historical High--Div YieldTTM12.97%Amplitude7.3800Historical Low21.3390Avg Price1Lot Size
About vTv Therapeutics Company
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
Company Profile
SymbolVTVT
Company NamevTv Therapeutics
Listing DateJul 30, 2015
Issue Price15.00
Founded2015
CEOMr. Paul J. Sekhri
MarketNASDAQ
Employees16
Fiscal Year Ends12-31
Address3980 Premier Drive,Suite 310
CityHigh Point
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27265
Phone1-336-841-0300
Company Executives
- Name
- Position
- Salary
- Paul J. Sekhri
- Chairman of the Board, President and Chief Executive Officer
- 650.91K
- Steven L. Tuch
- Executive Vice President and Chief Financial Officer
- 465.25K
- Richard S. Nelson
- Director and Executive Vice President, Corporate Development
- --
- Dr. Jonathan Isaacsohn
- Executive Chairman of the Board
- --
- Dr. Raymond Cheong, PhD
- Director
- --
- Daniel K. Spiegelman
- Director
- --
- Hersh Kozlov
- Director
- 100.13K
- Dr. Srinivas Akkaraju
- Director
- --
- Dr. Keith Harris
- Independent Director
- 107.63K
- Dr. Anne M. Phillips, M.D.
- Independent Director
- --
- Fahed Al-Marzooqi
- Independent Director
- 87.63K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.